Tag: Ng Kay Ian
AIM Vaccine taps S&C and Jingtian on HKD156m listing on HKEX
China’s biggest privately owned vaccine group AIM Vaccine enlisted legal advice from Sullivan & Cromwell (S&C) and Jingtian & Gongcheng for its debut on the HKEX
0
LATEST ON VANTAGE ASIA
Best-laid plans
The Chinese co-chair of IBA’s antitrust section talks about her ambition to broaden the horizons for the country's lawyers in the competition arena
Future Legal Leaders 2023
50 young and dynamic lawyers poised for great success and the common traits that define them
Crypto arts are all the rage among Indian celebrities, but scepticism remains due to the legal ambiguity
IBA’s first Chinese woman antitrust co-chair shares her career path
50 young and dynamic lawyers poised for great success and the common traits that define them
MOST READ ON VANTAGE ASIA
Compensation liability for directors’ neglect of liquidation duties
By Li Zhingyong, Grandway Law Offices
IP securitisation in China: origins, development and present status
By Li Yanbo and Wang Chenghao, Zhilin Law Firm
Correspondents
Handling customs price inspection and compliance
By Jia Xiaoning and Ning Jing, AllBright Law Offices
TCFD is not storm in a teacup
By Soumya De Mallik, Unnati Goel, Prithviraj Chauhan and Meeval Mariam Varghese, HSA Advocates